Literature DB >> 23075434

Short communication: HIV type 1 subtype C variants transmitted through the bottleneck of breastfeeding are sensitive to new generation broadly neutralizing antibodies directed against quaternary and CD4-binding site epitopes.

Elizabeth S Russell1, Suany Ojeda, Genevieve G Fouda, Steven R Meshnick, David Montefiori, Sallie R Permar, Ronald Swanstrom.   

Abstract

Mother-to-child transmission of HIV-1 subtype C can occur in utero, intrapartum, or via breast milk exposure. While not well understood, there are putative differences in the mechanisms involved with the distinct routes of vertical HIV transmission. Here, we address the question of whether specific viral characteristics are common to variants transmitted through breastfeeding that may facilitate evasion of innate or adaptive immune responses. We amplified the envelope gene (env) from the plasma of six infants during acute infection who were infected with HIV-1 subtype C through breastfeeding, and from three available matched maternal samples. We sequenced the full-length env genes in these subjects revealing heterogeneous viral populations in the mothers and homogeneous populations in the infants. In five infants, the viral population arose from a single variant, while two variants were detected in the remaining infant. Infant env sequences had fewer N-linked glycosylation sites and shorter sequences than those of the available matched maternal samples. Though the small size of the study precluded our ability to test statistical significance, these results are consistent with selection for virus with shorter variable loops and fewer glycosylation sites during transmission of HIV-1 subtype C in other settings. Transmitted envs were resistant to neutralization by antibodies 2G12 and 2F5, but were generally sensitive to the more broadly neutralizing PG9, PG16, and VRC01, indicating that this new generation of broadly neutralizing monoclonal antibodies could be efficacious in passive immunization strategies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23075434      PMCID: PMC3581069          DOI: 10.1089/AID.2012.0197

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  43 in total

Review 1.  Antiviral activities of lactoferrin.

Authors:  B W van der Strate; L Beljaars; G Molema; M C Harmsen; D K Meijer
Journal:  Antiviral Res       Date:  2001-12       Impact factor: 5.970

Review 2.  Chemokines as natural HIV antagonists.

Authors:  Alessia Verani; Paolo Lusso
Journal:  Curr Mol Med       Date:  2002-12       Impact factor: 2.222

3.  Compartmentalization of HIV-1 between breast milk and blood of HIV-infected mothers.

Authors:  Pierre Becquart; Nicolas Chomont; Pierre Roques; Ahidjo Ayouba; Michel D Kazatchkine; Laurent Bélec; Hakim Hocini
Journal:  Virology       Date:  2002-08-15       Impact factor: 3.616

4.  A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood.

Authors:  Stéphane Guindon; Olivier Gascuel
Journal:  Syst Biol       Date:  2003-10       Impact factor: 15.683

5.  Envelope glycoproteins of human immunodeficiency virus type 1 variants issued from mother-infant pairs display a wide spectrum of biological properties.

Authors:  Suzie Thenin; Tanawan Samleerat; Elsa Tavernier; Nicole Ngo-Giang-Huong; Gonzague Jourdain; Marc Lallemant; Francis Barin; Martine Braibant
Journal:  Virology       Date:  2012-02-04       Impact factor: 3.616

6.  A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences.

Authors:  M Kimura
Journal:  J Mol Evol       Date:  1980-12       Impact factor: 2.395

7.  Secretory leukocyte protease inhibitor inhibits infection of monocytes and lymphocytes with human immunodeficiency virus type 1 but does not interfere with transcytosis of cell-associated virus across tight epithelial barriers.

Authors:  H Hocini; P Becquart; H Bouhlal; H Adle-Biassette; M D Kazatchkine; L Bélec
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

8.  Diversity of the human immunodeficiency virus type 1 (HIV-1) env sequence after vertical transmission in mother-child pairs infected with HIV-1 subtype A.

Authors:  Chris Verhofstede; Els Demecheleer; Nancy De Cabooter; Philippe Gaillard; Fabian Mwanyumba; Patricia Claeys; Varsha Chohan; Kishorchandra Mandaliya; Marleen Temmerman; Jean Plum
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

Review 9.  Saliva and inhibition of HIV-1 infection: molecular mechanisms.

Authors:  D C Shugars; S P Sweet; D Malamud; S H Kazmi; K Page-Shafer; S J Challacombe
Journal:  Oral Dis       Date:  2002       Impact factor: 3.511

10.  The effect of Plasmodium falciparum malaria on peripheral and placental HIV-1 RNA concentrations in pregnant Malawian women.

Authors:  Victor Mwapasa; Stephen J Rogerson; Malcolm E Molyneux; Elizabeth T Abrams; Deborah D Kamwendo; Valentino M Lema; Eyob Tadesse; Ebbie Chaluluka; Paul E Wilson; Steven R Meshnick
Journal:  AIDS       Date:  2004-04-30       Impact factor: 4.177

View more
  14 in total

1.  Population pharmacokinetics analysis of VRC01, an HIV-1 broadly neutralizing monoclonal antibody, in healthy adults.

Authors:  Yunda Huang; Lily Zhang; Julie Ledgerwood; Nicole Grunenberg; Robert Bailer; Abby Isaacs; Kelly Seaton; Kenneth H Mayer; Edmund Capparelli; Larry Corey; Peter B Gilbert
Journal:  MAbs       Date:  2017-04-03       Impact factor: 5.857

2.  Vertical HIV-1 Transmission in the Setting of Maternal Broad and Potent Antibody Responses.

Authors:  Joshua J Tu; Amit Kumar; Elena E Giorgi; Joshua Eudailey; Celia C LaBranche; David R Martinez; Genevieve G Fouda; Yvetane Moreau; Allison Thomas; David Montefiori; Feng Gao; Manish Sagar; Sallie R Permar
Journal:  J Virol       Date:  2022-05-10       Impact factor: 6.549

Review 3.  The oral mucosa immune environment and oral transmission of HIV/SIV.

Authors:  Lianna F Wood; Ann Chahroudi; Hui-Ling Chen; Heather B Jaspan; Donald L Sodora
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

4.  Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults.

Authors:  J E Ledgerwood; E E Coates; G Yamshchikov; J G Saunders; L Holman; M E Enama; A DeZure; R M Lynch; I Gordon; S Plummer; C S Hendel; A Pegu; M Conan-Cibotti; S Sitar; R T Bailer; S Narpala; A McDermott; M Louder; S O'Dell; S Mohan; J P Pandey; R M Schwartz; Z Hu; R A Koup; E Capparelli; J R Mascola; B S Graham
Journal:  Clin Exp Immunol       Date:  2015-09-24       Impact factor: 4.330

Review 5.  New concepts in HIV-1 vaccine development.

Authors:  Kathryn E Stephenson; Helen T D'Couto; Dan H Barouch
Journal:  Curr Opin Immunol       Date:  2016-06-03       Impact factor: 7.486

6.  The Impact of IgG transplacental transfer on early life immunity.

Authors:  Genevieve G Fouda; David R Martinez; Geeta K Swamy; Sallie R Permar
Journal:  Immunohorizons       Date:  2018-01-01

7.  Computational analysis of antibody dynamics identifies recent HIV-1 infection.

Authors:  Kelly E Seaton; Nathan A Vandergrift; Aaron W Deal; Wes Rountree; John Bainbridge; Eduard Grebe; David A Anderson; Sheetal Sawant; Xiaoying Shen; Nicole L Yates; Thomas N Denny; Hua-Xin Liao; Barton F Haynes; Merlin L Robb; Neil Parkin; Breno R Santos; Nigel Garrett; Matthew A Price; Denise Naniche; Ann C Duerr; Sheila Keating; Dylan Hampton; Shelley Facente; Kara Marson; Alex Welte; Christopher D Pilcher; Myron S Cohen; Georgia D Tomaras
Journal:  JCI Insight       Date:  2017-12-21

8.  Postnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variants.

Authors:  Genevieve G Fouda; Tatenda Mahlokozera; Jesus F Salazar-Gonzalez; Maria G Salazar; Gerald Learn; Surender B Kumar; S Moses Dennison; Elizabeth Russell; Katherine Rizzolo; Frederick Jaeger; Fangping Cai; Nathan A Vandergrift; Feng Gao; Beatrice Hahn; George M Shaw; Christina Ochsenbauer; Ronald Swanstrom; Steve Meshnick; Victor Mwapasa; Linda Kalilani; Susan Fiscus; David Montefiori; Barton Haynes; Jesse Kwiek; S Munir Alam; Sallie R Permar
Journal:  Retrovirology       Date:  2013-01-10       Impact factor: 4.602

9.  Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in breast milk following single-dose nevirapine prophylaxis.

Authors:  Sallie R Permar; Maria G Salazar; Feng Gao; Fangping Cai; Gerald H Learn; Linda Kalilani; Beatrice H Hahn; George M Shaw; Jesus F Salazar-Gonzalez
Journal:  Retrovirology       Date:  2013-08-14       Impact factor: 4.602

Review 10.  The role of neutralizing antibodies in prevention of HIV-1 infection: what can we learn from the mother-to-child transmission context?

Authors:  Martine Braibant; Francis Barin
Journal:  Retrovirology       Date:  2013-10-07       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.